A

Andrea Loreto

The University of Sydney

ORCID: 0000-0001-6535-6436

Publishes on Sirtuins and Resveratrol in Medicine, Nerve injury and regeneration, Signaling Pathways in Disease. 67 papers and 1.7k citations.

PubIndex Score60Top 40% · mid-careerHow it's scored

67Publications

1.7kTotal Citations

First publication: 1992First senior author: 2019

Sirtuins and Resveratrol in Medicine Nerve injury and regeneration Signaling Pathways in Disease Calcium signaling and nucleotide metabolism Autophagy in Disease and Therapy

Top publicationsby citations

NMNAT2 is a druggable target to drive neuronal NAD production

James R. Tribble, Pete A. Williams, Carmine Varricchio et al.|Nature Communications|2024

Cited by 36

Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration

Andrea Loreto, Michael P. Coleman|bioRxiv (Cold Spring Harbor Laboratory)|2019

Cited by 10

SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides

Andrea Loreto, Richard Wade‐Martins|bioRxiv (Cold Spring Harbor Laboratory)|2024

Cited by 5